Clinical Study
HLA-G Polymorphism (rs16375) and Acute Rejection in Liver Transplant Recipients
Table 1
Demographics of liver graft recipients.
| | Parameter | ARs (%) | NARs (%) |
| | Number of patients | 21 (21) | 79 (79) | | Recipient gender | | | | Male | 13 (68) | 32 (61) | | Female | 8 (32) | 47 (39) | | Cold ischemic time (hour) | | | | Recipient age (years, mean ± SD) | | | | Donor age (years, mean ± SD) | | | | Donor gender | | | | Male | 12 (58) | 49 (62) | | Female | 9 (42) | 30 (38) | | Primary disease | | | | Hepatitis B () | 6 (30) | 22 (27) | | Cryptogenic () | 4 (21) | 20 (26) | | Primary sclerosing cholangitis () | 5 (24) | 8 (10) | | Autoimmune hepatitis () | 3 (15) | 8 (10) | | Biliary atresia () | 0 | 6 (8) | | Hypercholesteremia () | 0 | 5 (7) | | Wilson disease () | 0 | 3 (4) | | Tyrosinemia () | 0 | 2 (2) | | Alcoholism () | 0 | 2 (2) | | Crigler Najjar syndrome () | 0 | 2 (2) | | Hepatocellular carcinoma () | 1 (5) | 1 (1) | | Hepatitis C virus () | 0 | 1 (1) | | Fulminate hepatitis () | 1 (5) | 0 | | Living donor | 8 (38) | 10 (13) | | Deceased donor | 13 (62) | 69 (87) | | Histological grade of rejection | | | | I | 13 (61) | | | II | 5 (24) | | | III | 3 (15) | |
|
|
ARs: acute rejection; NARs: nonacute rejection.
|
